α1-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease

Journal of Neural Transmission

Volumn 103, Issue 10, 1996, Pages 1205-1210

  Muramatsu, T ^a   Matsushita, S ^a   Arai, H ^b   Sasaki, H ^b   Higuchi, S ^a  

^a KURIHAMA NATIONAL HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1 antichymotrypsin; Alzheimer's disease; Apolipoprotein E; Gene polymorphism

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN A4; APOLIPOPROTEIN E4; CHAPERONE; DNA MARKER;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; DISEASE SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0029841606     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01271205     Document Type: Article

References (19)

1. Abraham CR, Selkoe DJ, Potter H (1988) Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487-501
2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel PC, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
3. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST (1995) APOE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nature Genet 10: 486-488
4. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372: 92-94
5. Matsubara E, Hirai S, Amari M, Shoji M, Yamaguchi H, Okamoto K, Ishiguro K, Harigaya Y, Wakabayashi, K (1990) α1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann Neurol 28: 561-567
6. Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang M-X, Maestre G, Ngai C, Tycko B, Ginsberg H (1993) The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 34: 752-754
7. McKhann G, Drachman D, Holstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944
8. Probst A, Brunnschweiler H, Lautenschlager C, Ulrich J (1987) A special type of senile plaque, possibly an initial stage. Acta Neuropathol 74: 133-141
9. Randall LL, Hardy SJS (1989) Unity in function in the absence of consensus in sequence: role of leader peptides in export. Science 243: 1156-1159
10. Rozemuller JM, Abbink JJ, Kamp AM, Stam FC, Hack CE, Eikelenboom P (1991) Distribution pattern and functional state of α1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. Acta Neuropathol 82: 200-207
11. Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, Strittmatter WJ (1994) Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. J Clin Invest 94: 860-869
12. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487-498
13. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high avididy binding to β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977-1981
14. Talbot C, Houlden H, Craddock N, Crook R, Hutton M, Lendon C, Prihar G, Morris JC, Hardy J, Goate A (1996) Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. NeuroReport 7: 534-536
15. Thome J, Baumer A, Kornhuber J, Rösler M, Riederer P (1995) Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome. J Neural Transm [P-D Sect] 10: 207-212
16. Tsuda M, Sei Y, Yamamura M, Yamamoto M, Shinohara Y (1992) Detection of a new mutant α-1-antychymotrypsin in patients with occlusive-cerebrovascular disease. FEBS Lett 304: 66-68
17. Wenham PR, Price WH, Blundell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337: 1158-1159
18. Wisniewski T, Frangione B (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135: 235-238
19. Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 145: 1030-1035